Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Integra LifeSciences Holdings Corporation (IART:NASDAQ), powered by AI.
Integra LifeSciences Holdings Corporation is currently trading at $9.53. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Integra LifeSciences Holdings Corporation on Alpha Lenz.
Integra LifeSciences Holdings Corporation's P/E ratio is -105.9.
“Integra LifeSciences Holdings Corporation trades at a P/E of -105.9 (undervalued) with modest ROE of -0.4%.”
Ask for details →Integra LifeSciences Holdings Corporation is a prominent company in the medical device field, focused on providing innovative solutions for patients and healthcare professionals globally. Known for its comprehensive portfolio, Integra LifeSciences develops, manufactures, and markets medical devices used primarily in neurosurgery, reconstructive surgery, and regenerative medicine. The company's offerings include a variety of implants, devices, and instruments designed to improve surgical procedures and outcomes. Integra LifeSciences serves multiple sectors within the healthcare industry, including hospitals, surgical centers, and rehabilitation facilities. The organization's commitment to advancing medical technology positions it as a critical player in enhancing patient care and driving medical advancements. Founded in 1989, Integra LifeSciences has established a significant presence in both domestic and international markets, continually striving to innovate and improve the quality of life for patients worldwide. Its role in the healthcare sector underscores the importance of technological development in medical applications, impacting numerous lives through its research and development efforts.
“Integra LifeSciences Holdings Corporation trades at a P/E of -105.9 (undervalued) with modest ROE of -0.4%.”
Ask for details →